PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Andreas Fahl Medizintechnik-vertrieb GMBH

USPTO PatentsView assignee record - 26 granted patents across 2 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Andreas ranks #11,540 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 2 technology areas.

#11,540
of 49,997 US assignees by volume
16th percentile
by Innovation Score (25.0/100)
6.3
avg claims per patent
+8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11540 · Foreign Corporation #11,540 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 26 grants
  • UPPER-Q #11,540/49,997
  • PHOTO-FINISH Allstate Solutions…
  • CPC-NARROW A61F · 2 areas
  • INNOV-THIN 25.0/100
  • CLAIMS-SPARSE 6.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT +8% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Allstate Solutions Private Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Andreas’s 25.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Andreas

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Andreas's Innovation Score is 25.0/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Andreas?

Each dot is one of Andreas’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Andreas’s own 6.3 claims/patent is at or below the 17.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Andreas vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 25.92626.1 510152025 Granted patents (volume) Avg claims / patent Allstate Solutions Private Limited - 26, 19Allstate Solution…American Honda Motor Co., Inc. - 26, 7.85American Honda Mo…Amneal Pharmaceuticals LLC - 26, 17.35Amneal Pharmaceut…Amobee, Inc. - 26, 18.04AmobeeAOD Holdings, LLC - 26, 18.04AOD HoldingsAqua Co., Ltd. - 26, 8.04AquaART Medical Ltd. - 26, 20ART MedicalArturo Salice S.P.A. - 26, 13.69Arturo Salice S P…Andreas Fahl Medizintechnik-vertrieb GMBH - 26, 6.35Andreas Fahl Medi…
Andreas vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Andreas's grants concentrate

Andreas Fahl Medizintechnik-vertrieb GMBH is a focused PatentsView assignee: 2 CPC subclasses with 46.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2015. By volume, Andreas sits between Allstate Solutions Private Limited and Arturo Salice S.P.A..

Andreas's three-year grant acceleration

Andreas Fahl Medizintechnik-vertrieb GMBH shows 8 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Andreas's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Andreas holds 26 patents at rank #11,533, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Andreas

By rank, the assignees closest to #11,533 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Andreas's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Andreas, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Andreas ranks #539 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (25 here).

Infobridge PTE. Ltd. 25 Comindware Ltd. 25 Anteryon Wafer Optics B.V. 25 Jaquish Biomedical Corporation 25

Andreas's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 16th percentile higher than 16% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20152016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Andreas Fahl Medizintechnik-vertrieb GMBH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 3.8%
2016 2 7.7%
2017 2 7.7%
2018 1 3.8%
2019 6 23.1%
2020 2 7.7%
2021 3 11.5%
2022 2 7.7%
2023 5 19.2%
2024 1 3.8%
2025partial year 1 3.8%

Which technologies does Andreas Fahl Medizintechnik-vertrieb GMBH patent most?

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Andreas Fahl Medizintechnik-vertrieb GMBH's patent record in context - here's where to go next.

  • Andreas Fahl Medizintechnik-vertrieb GMBH's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 46.2% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #11,540 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Andreas Fahl Medizintechnik-vertrieb GMBH against Allstate Solutions Private Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 25.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.